Skip to content

Optical diagnosis versus laser measurement of polyps* size during colonoscopy and implications for surveillance

Optical diagnosis versus laser measurement of polyps* size during colonoscopy and implications for surveillance - Polyp size study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51774
Enrollment
60
Registered
2023-05-30
Start date
2025-01-13
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyps precursors of colorectal cancer

Interventions

Optical assessment will be performed upon identification of the polyp. Then, measurement with AccuMeasure and biopsy forceps will be performed in a randomized order. The endoscopist will remain blin

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Adult patients (>18 years) • Scheduled for screening, surveillance, or diagnostic colonoscopy • Polyps of all forms

Exclusion criteria

Exclusion criteria: • Therapeutic colonoscopy • Inflammatory bowel disease (IBD) • American Society of Anesthesiologists score of >3 • Inadequate bowel preparation (Boston bowel preparation scale score [BBPS]

Design outcomes

Primary

MeasureTime frame
The primary endpoint of this study is establishing Cohens* Kappa coefficient in determining the size of polyps for the following categories: =10mm, for the interobserver agreement between AccuMeasure and biopsy forceps assisted measurement.

Secondary

MeasureTime frame
Secondary objectives are to assess: • Reproducibility of AM using successive measurements of the same polyp; • Precision estimate of AM as compared to optical- and biopsy forceps assisted assessment; • Size differences for optical-, biopsy forceps-, and AM assessment as compared to pathology size measurement; • Subgroups based on polyp morphology (i.e., sessile or adenomatous lesions); • Time needed to measure polyp size and learning curve; • Endoscopist advised surveillance interval based on optical assessment during colonoscopy, on measurement with an open biopsy forceps, and on measurement with AccuMeasure. • Safety, in terms of (severe) adverse events up to 30 days post-procedure

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)